Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q3 2022)

As of Sep 30, 2022, the Muhlenkamp & Co portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 01, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2022, the filing reported:

Reductions - None reported
Complete Exits - Morgan Stanley, Pfizer, Inc.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q3 2022
AAPL
Apple Inc.
 Buy
+5
Q3 2022
AMLP
Alerian MLP ETF
 Buy
+2,957
Q3 2022
AVGO
Broadcom Inc.
 Buy
+23
Q3 2022
BMY
Bristol-Myers Squibb Company
 Buy
+1,197
Q3 2022
BRK-B
Berkshire Hathaway Inc. New
 Buy
+200
Q3 2022
CCJ
Cameco Corporation
 Buy
+558
Q3 2022
CVS
CVS Health Corporation
 Buy
+1,078
Q3 2022
DOW
Dow Inc.
 Buy
+781
Q3 2022
EQT
EQT Corporation
 Buy
+1,590
Q3 2022
FNV
Franco-Nevada Corporation
 Buy
+2,861
Q3 2022
GLD
SPDR Gold Trust
 Buy
+3,840
Q3 2022
KEX
Kirby Corporation
 Buy
+634
Q3 2022
MCHP
Microchip Technology Incorporat
 Buy
+263
Q3 2022
MCK
McKesson Corporation
 Buy
+285
Q3 2022
MS
Morgan Stanley
 Sell - Position Exit
-10,805
Q3 2022
MSFT
Microsoft Corporation
 Buy
+44
Q3 2022
MTZ
MasTec, Inc.
 Buy
+446
Q3 2022
NMIH
NMI Holdings Inc
 Buy
+1,052
Q3 2022
OXY
Occidental Petroleum Corporatio
 Buy
+1,201
Q3 2022
PFE
Pfizer, Inc.
 Sell - Position Exit
-24,164
Q3 2022
RGLD
Royal Gold, Inc.
 Buy
+4,752
Q3 2022
SLB
Schlumberger N.V.
 Buy
+3,959
Q3 2022
SPDN
Direxion Daily S&P 500 Bear 1X
Buy - Position Entry
+652,921
Q3 2022
UNH
UnitedHealth Group Incorporated
 Buy
+212
Q3 2022
WAB
Westinghouse Air Brake Technolo
 Buy
+91